IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q1 2019 Holdings

Filed 2019-05-14 | 52 holdings | $342.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Sanofi(SNY)ASPONSORED ADR80105N105$14.7M332,4024.3%
Nuvasive Inc(NUVAGBP)ACOM670704105$18.8M330,6015.5%
Danaher Corporation(DHR)ACOM235851102$21.0M158,7646.1%
Zogenix IncACOM NEW98978L204$27.3M495,4298.0%
R1 RCM IncACOM749397105$28.7M2,963,6598.4%
Glaxosmithkline PLCASPONSORED ADR37733W105$34.1M803,1859.9%
Amarin Corp PLCASPONS ADR NEW023111206$42.8M2,060,28712.5%
PreviousPage 2 of 2